MedTrace Logo

Testing the Characteristics of Platelet Rich Plasma in Sports Medicine

NCT02726464 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-02-23

No results posted yet for this study

Summary

This is an observational study that evaluates the characteristics of Platelet Rich Plasma used in the therapy and treatment of musculoskeletal injuries and degenerative joint diseases.

A sample of the PRP will be tested for platelet and microparticle content using dynamic light scattering to determine if there is a relationship between the composition and the treatment outcome.

Conditions

Sponsors & Collaborators

  • LightIntegra Technology

    collaborator INDUSTRY

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Don McKenzie, MD, PhD, LLD · University of British Columbia

  • Jennifer Leung, MSc · LightIntegra Technology Inc

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-03-31
Completion
2018-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02726464 on ClinicalTrials.gov